54.48 -0.08 (-0.15%)
After hours: 4:16PM EDT
|Bid||53.00 x 1100|
|Ask||55.60 x 1100|
|Day's Range||53.00 - 57.69|
|52 Week Range||24.58 - 68.39|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||46.75|
Several IPO stocks have been on a tear lately as innovative products fuel booming sales. Most aren't profitable, but Wall Street doesn't seem to mind.
This medical device maker is growing rapidly and has already treated its investors to huge gains. Here's why Wall Street is so excited about where this company is heading.
A look at the shareholders of ShockWave Medical, Inc. (NASDAQ:SWAV) can tell us which group is most powerful...
SANTA CLARA, Calif., June 10, 2019 -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat.
An IPO that happened on Thursday, a filing for another one, and more than $600 million in funding tops the Bay Area's venture news heading into the holiday weekend.
All six have doubled in value — or more — since their Wall Street debuts and they are either headquartered in the Bay Area or backed by investors from the region.
Shockwave Medical, Inc. (SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, announced today that the Company has appointed Keith D. Dawkins, M.D. as Chief Medical Officer. “Given the challenges associated with treating calcium throughout the cardiovascular system, joining Shockwave and contributing to the development of what will likely become the new standard of care for calcium modification was an attractive opportunity,” said Dr. Dawkins.
The medical device maker's first earnings report as a public company featured explosive revenue growth and upbeat full-year guidance.
A South San Francisco biotech's offering soared on Thursday, but a San Mateo ruggedized smartphone maker's priced well below its targets. Here's more on that and other Bay Area founder and funder news at the end of the week.
The Fremont, California-based company said it had a loss of $1.37 per share. The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research ...
SANTA CLARA, Calif., May 08, 2019 -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat.
The measure of the health of the venture and startup world has dropped for two straight quarters now, down from 17-year highs by about 15 percent.
SANTA CLARA, Calif., May 01, 2019 -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat.
The company joins joins what could be a busy month for Bay Area IPOs in May, which is expected to include Uber's massive offering, Slack's direct listing and the market debut of South San Francisco biotech Cortexyme.